Latest article
A novel cell remedy for kind I diabetes mellitus — ScienceDaily
Type I diabetes mellitus (T1D) is an autoimmune disease that results in the permanent loss of insulin-producing beta cells in the pancreas. In...
ADOCIA Presents Medical Outcomes on M1Pram on the 14th Worldwide Convention on Superior Applied...
Lyon, France - (BUSINESS WIRE) - Regulatory news:
ADOCIA (Euronext Paris: FR0011184241 - ADOC), a clinical-stage biopharmaceutical...